SYRE
#1057
Spyre Therapeutics, Inc. - Common Stock
90.3 6 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.48%
Monthly Change
-8.04%
6 month change
+121.20%
Year Change
+277.92%
Previous Close
93.6 2
Open
90.3 6
Low
90.3 6
High
90.3 6
Volume
241
Financials
- Market Capitalization 7.97 B
- Employee 112
- Founded 2013
- CEO N/A
- Website www.spyre.com
- Headquarter Delaware, United States
- FIGI BBG0067L94B2
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-16.55
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1024 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.97 USD | +0.01% | +0.13% | +0.54% | +151.86% | 8.40 B USD | ||
| 1040 |  TGTX TG Therapeutics, Inc. - Common Stock | 53.93 USD | -3.21% | +1.39% | +0.88% | +83.62% | 8.26 B USD | ||
| 1090 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 107.17 USD | -4.76% | -4.56% | +1.60% | -2.85% | 7.38 B USD | ||
| 1118 |  SRRK Scholar Rock Holding Corporation - Common Stock | 57.80 USD | -2.46% | +1.76% | +17.53% | +92.54% | 7.04 B USD |
Frequently asked questions about Spyre Therapeutics, Inc. Common Stock
What is the Spyre Therapeutics, Inc. Common Stock stock price today?
The current price of Spyre Therapeutics, Inc. Common Stock (SYRE) is 90.36. Over the past 24 hours, the stock has changed by -3.48%. Follow the SYRE chart for real-time price dynamics.
What is the stock ticker of Spyre Therapeutics, Inc. Common Stock?
Spyre Therapeutics, Inc. Common Stock trades under the ticker SYRE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Spyre Therapeutics, Inc. Common Stock stock going up?
SYRE has changed by -15.15% over the last week, -8.04% over the last month, and +277.92% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Spyre Therapeutics, Inc. Common Stock?
Spyre Therapeutics, Inc. Common Stock currently has a market capitalization of 7.97 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Spyre Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Spyre Therapeutics, Inc. Common Stock reported earnings of -0.35 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Spyre Therapeutics, Inc. Common Stock revenue for the last quarter?
Spyre Therapeutics, Inc. Common Stock reported quarterly revenue of -4.6 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Spyre Therapeutics, Inc. Common Stock net income for the last quarter?
Spyre Therapeutics, Inc. Common Stock reported net income of -36.2 M for the last quarter. The previous quarter showed -69 M, which means net income changed by +47.54%.
How many employees does Spyre Therapeutics, Inc. Common Stock have?
As of the latest available data, Spyre Therapeutics, Inc. Common Stock has 112 employees. Workforce size can provide additional context about the company's scale and operations.
What is Spyre Therapeutics, Inc. Common Stock EBITDA?
Spyre Therapeutics, Inc. Common Stock EBITDA is -49.34 M, and its EBITDA margin is 1 071.8%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Spyre Therapeutics, Inc. Common Stock stock?
You can buy Spyre Therapeutics, Inc. Common Stock (SYRE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Spyre Therapeutics, Inc. Common Stock stock?
Investing in Spyre Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SYRE chart and related analysis on metatrader.com as part of your research.